Alpha Cognition Ownership
| ACOGF Stock | USD 6.62 0.17 2.50% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Alpha |
Alpha OTC Stock Ownership Analysis
About 30.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.17. Alpha Cognition had not issued any dividends in recent years. Alpha Cognition Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for Alzheimers disease and amyotrophic lateral sclerosis . Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada. Alpha Cognition is traded on OTC Exchange in the United States.The quote for Alpha Cognition is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Alpha Cognition go to https://www.alphacognition.com.Currently Active Assets on Macroaxis
Other Information on Investing in Alpha OTC Stock
Alpha Cognition financial ratios help investors to determine whether Alpha OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alpha with respect to the benefits of owning Alpha Cognition security.